Nomad Neuroscience
Nomad Neuroscience is a London, UK-based neurotech startup developing "nomad," an ear-worn wearable device that continuously monitors heart rate variability (HRV), resting heart rate and sleep signals, delivering gentle real-time (sub-one-second) stimulation to achieve "closed-loop neuromodulation" — a category previously limited to surgical implants.
Position in SVTR
Snapshot 2026-10-28- Startup SignalsRankedof 2,177new
- Life SciencesRankedof 231
- BCIRankedof 16
- SportsRankedof 14
About
Nomad Neuroscience is a London, UK-based neurotech startup developing "nomad," an ear-worn wearable device that continuously monitors heart rate variability (HRV), resting heart rate and sleep signals, delivering gentle real-time (sub-one-second) stimulation to achieve "closed-loop neuromodulation" — a category previously limited to surgical implants. The product targets recovery, focus, sleep and pressure management, initially aimed at athletes. The company emphasizes on-device signal processing (privacy-focused), open-format data export, and user data ownership, and partners with University College London (UCL), Queen Mary University of London, Royal Holloway, University of London, and UC San Diego on research. Per its website, beta launch is planned for Q4 2026, with production units targeted for 2028.
Capital graph
Founders / team· 4
Comparable companies· by market
This company
BusinessLatest roundTotal raisedDate- Nomad Neuroscience
Nomad Neuroscience is a London, UK-based neurotech startup developing "nomad," an ear-worn wearable device that continuously monitors heart rate variability (HRV), resting heart rate and sleep signals, delivering gentle real-time (sub-one-second) stimulation to achieve "closed-loop neuromodulation" — a category previously limited to surgical implants. The product targets recovery, focus, sleep and pressure management, initially aimed at athletes. The company emphasizes on-device signal processing (privacy-focused), open-format data export, and user data ownership, and partners with University College London (UCL), Queen Mary University of London, Royal Holloway, University of London, and UC San Diego on research. Per its website, beta launch is planned for Q4 2026, with production units targeted for 2028.
—
United States
BusinessLatest roundTotal raisedDate- Coya
Health and longevity management combining wearable data, human coaches and an AI assistant for enterprises and individuals, including dedicated women's health programs.
— - Blackrock Neurotech
Develops brain-computer interface technology designed to help patients with paralysis or other neurological conditions control digital devices and regain mobility
Undisclosed · $200M · 2024-05
$200M - Beacon Biosignals
EEG diagnostics and precision medicine platform combining wearable EEG with AI
Series B · $183M · 2025-11
$183M
China
BusinessLatest roundTotal raisedDate- 格式塔科技
Ultrasound brain-computer interface for whole-brain read/write, treating chronic pain, stroke rehabilitation, PTSD and other neurological conditions
Angel · $80M · 2026-07
$80M - BCI-Sonics
Non-invasive AI ultrasound brain-computer interface (transcranial focused ultrasound neuromodulation + multimodal brain reading and AI neural decoding)
Series A · $42M · 2026-09
$42M - 神复健行
Implantable brain-spine interface to restore walking in paralyzed patients; products in FDA Breakthrough Device pathway
$42M
$42M
Europe
BusinessLatest roundTotal raisedDate- Neurosoft Bioelectronics
Flexible, stretchable, non-penetrating brain-computer interfaces and neural electrodes to record/stimulate brain-surface activity
Seed · $20M · 2026-05
$20M - MintNeuro
Imperial College London spinout developing composable chip modules for neural signal acquisition, electrical stimulation, on-chip processing and wireless transmission, for BCI and active implant makers
Undisclosed · 2026-10
— - InBrain Neuroelectronics
Graphene-based brain-computer interface technology for neurological disorders such as Parkinson's disease.
Series B · $50M · 2024-11
$50M
Other / unspecified
BusinessLatest roundTotal raisedDate- Brain.space
Non-invasive brain monitoring platform with real-time neural data analysis
Series A · $11M · 2025-03
$11M - 脑思科技
Brain-computer interface electrodes and neural decoding systems
Angel · $10M · 2026-05
$10M - Vital Biosciences
Diagnostic technology developing the "revolutionary" blood test VitalOne
Undisclosed · $48M · 2023-07
$48M
Confirmed rounds only. Matched on subsector, sector, stage and funding scale — each verifiable on the company profiles.
Investors that may fit
Ranked by each firm’s deals in this sector over the last 24 months, weighted by nearby stage and shared geography. Indicative only — no rating judgment.